Your browser doesn't support javascript.
loading
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer.
Loupakis, Fotios; Biason, Paola; Prete, Alessandra Anna; Cremolini, Chiara; Pietrantonio, Filippo; Pella, Nicoletta; Dell'Aquila, Emanuela; Sperti, Elisa; Zichi, Clizia; Intini, Rossana; Dadduzio, Vincenzo; Schirripa, Marta; Bergamo, Francesca; Antoniotti, Carlotta; Morano, Federica; Cortiula, Francesco; De Maglio, Giovanna; Rimassa, Lorenza; Smiroldo, Valeria; Calvetti, Lorenzo; Aprile, Giuseppe; Salvatore, Lisa; Santini, Daniele; Munari, Giada; Salmaso, Roberta; Guzzardo, Vincenza; Mescoli, Claudia; Lonardi, Sara; Rugge, Massimo; Zagonel, Vittorina; Di Maio, Massimo; Fassan, Matteo.
Afiliación
  • Loupakis F; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. fotios.loupakis@iov.veneto.it.
  • Biason P; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Prete AA; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pella N; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Dell'Aquila E; Department of Oncology, University and General Hospital, Udine, Italy.
  • Sperti E; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Zichi C; Department of Oncology, University of Turin at Umberto I "Ordine Mauriziano" Hospital, Turin, Italy.
  • Intini R; Department of Oncology, University of Turin at Umberto I "Ordine Mauriziano" Hospital, Turin, Italy.
  • Dadduzio V; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Schirripa M; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Bergamo F; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Antoniotti C; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Morano F; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Cortiula F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Maglio G; Department of Oncology, University and General Hospital, Udine, Italy.
  • Rimassa L; Department of Medicine (DAME), University of Udine, Udine, Italy.
  • Smiroldo V; Department of Pathology, University Hospital of Udine, Udine, Italy.
  • Calvetti L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS Rozzano, Milan, Italy.
  • Aprile G; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS Rozzano, Milan, Italy.
  • Salvatore L; Department of Oncology, General Hospital San Bortolo, Unità Locale Socio-Sanitaria 8 Berica, Vicenza, Italy.
  • Santini D; Department of Oncology, General Hospital San Bortolo, Unità Locale Socio-Sanitaria 8 Berica, Vicenza, Italy.
  • Munari G; Unit of Oncology, Polyclinic GB Rossi, AOUI, Verona, Italy.
  • Salmaso R; U.O.C Oncologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
  • Guzzardo V; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Mescoli C; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Lonardi S; Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Rugge M; Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Zagonel V; Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Di Maio M; Surgical Pathology & Cytopathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Fassan M; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Br J Cancer ; 121(7): 593-599, 2019 10.
Article en En | MEDLINE | ID: mdl-31474758
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas B-raf / Queratina-7 / Factor de Transcripción CDX2 / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas B-raf / Queratina-7 / Factor de Transcripción CDX2 / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Italia